RELATIONSHIP OF CYP2D6 GENETIC POLYMORPHISMS AND THE PHARMACOKINETICS OF TRAMADOL IN CHINESE VOLUNTEERS

被引：0
|
作者：
Li, Qin [1 ]
Zhong, Dafang [2 ]
Lou, Jianshi [1 ]
Wang, Rui [3 ]
机构：
[1] Tianjin Med Univ, Dept Pharmacol, Tianjin 300070, Peoples R China
[2] Chinese Acad Sci, Shanghai Inst Mat Med, Ctr Drug Metab & Pharmacokinet Res, Shanghai 200031, Peoples R China
[3] Chinese People Liberat Army Gen Hosp, Dept Clin Pharmacol, Beijing 100853, Peoples R China
来源：
DRUG METABOLISM REVIEWS | 2008年 / 40卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
60
引用
下载
收藏
页码：37 / 37
页数：1
相关论文
共 50 条
  • [1] Relationship of CYP2D6 genetic polymorphisms and the pharmacokinetics of tramadol in Chinese volunteers
    Li, Q.
    Wang, R.
    Guo, Y.
    Wen, S.
    Xu, L.
    Wang, S.
    JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, 2010, 35 (02) : 239 - 247
  • [2] Effects of CYP2D6 genetic polymorphisms on the pharmacokinetics of tramadol and its active metabolite
    Lim, Hye-Jin
    Kim, B. S. Dong-Hyun
    Kim, Young-Hoon
    Kim, Se-Hyung
    Byeon, Ji-Yeong
    Lee, Seok-Yong
    PHARMACOTHERAPY, 2015, 35 (11): : E315 - E315
  • [3] Impact of CYP2D6 genetic polymorphism on tramadol pharmacokinetics and pharmacodynamics
    Gan, Siew Hua
    Ismail, Rusli
    Adnan, Wan Aasim Wan
    Zulmi, Wan
    MOLECULAR DIAGNOSIS & THERAPY, 2007, 11 (03) : 171 - 181
  • [4] Impact of CYP2D6 Genetic Polymorphism on Tramadol Pharmacokinetics and Pharmacodynamics
    Siew Hua Gan
    Rush Ismail
    Wan Aasim Wan Adnan
    Wan Zulmi
    Molecular Diagnosis & Therapy, 2007, 11 (3) : 171 - 181
  • [5] Genetic polymorphisms of CYP2D6 in Chinese mainland
    Ji, L
    Pan, SX
    Wu, JM
    Marti-Jaun, J
    Hersberger, M
    CHINESE MEDICAL JOURNAL, 2002, 115 (12) : 1780 - 1784
  • [6] Impact of CYP2D6 polymorphisms on the pharmacokinetics of lovastatin in Chinese subjects
    Ophelia Qi Ping Yin
    Valiant Wah Lun Mak
    Miao Hu
    Benny Siu Pong Fok
    Moses Sing Sum Chow
    Brian Tomlinson
    European Journal of Clinical Pharmacology, 2012, 68 : 943 - 949
  • [7] Impact of CYP2D6 polymorphisms on the pharmacokinetics of lovastatin in Chinese subjects
    Yin, Ophelia Qi Ping
    Mak, Valiant Wah Lun
    Hu, Miao
    Fok, Benny Siu Pong
    Chow, Moses Sing Sum
    Tomlinson, Brian
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2012, 68 (06) : 943 - 949
  • [8] CYP2D6*10 genetic polymorphisms and Bisoprolol's pharmacokinetics
    Zhang, Zhi-guo
    Wang, Jing
    Li, Hong-ying
    Sun, Shu-bo
    ACTA PHARMACOLOGICA SINICA, 2013, 34 : 145 - 145
  • [9] Effect of CYP2D6 genetic polymorphisms on pharmacokinetics of tropisetron.
    Oh, D
    Kim, M
    Cho, J
    Lim, H
    Hong, K
    Chung, J
    Bae, K
    Yi, S
    Shin, S
    Jang, I
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2003, 73 (02) : P21 - P21
  • [10] Involvement of CYP2D6 and CYP2B6 on tramadol pharmacokinetics
    Saiz-Rodriguez, Miriam
    Ochoa, Dolores
    Roman, Manuel
    Zubiaur, Pablo
    Koller, Dora
    Mejia, Gina
    Abad-Santos, Francisco
    PHARMACOGENOMICS, 2020, 21 (10) : 663 - 675
12345